Bio-Gene Technology Ltd (BGT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.811x

Based on the latest financial reports, Bio-Gene Technology Ltd (BGT) has a cash flow conversion efficiency ratio of -0.811x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-946.61K ≈ $-669.78K USD) by net assets (AU$1.17 Million ≈ $825.57K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bio-Gene Technology Ltd (BGT) defensive interval to measure how many days the company can operate on defensive assets alone.

Bio-Gene Technology Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Bio-Gene Technology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bio-Gene Technology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Gene Technology Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dunedin Income Growth Investment Trust PLC LSE:DIG	0.016x
ASN Broker Public Company Limited BK:ASN	0.027x
Sentral Mitra Informatika Tbk PT JK:LUCK	-0.026x
K9 Gold Corp V:KNC	-0.612x
Collplant Biotechnologies Ltd NASDAQ:CLGN	-0.309x
Hydrocarbon Dynamics Ltd AU:HCD	-0.355x
Golden Sun Education Group Ltd NASDAQ:GSUN	-0.091x
Megaron SA WAR:MEG	0.020x

Annual Cash Flow Conversion Efficiency for Bio-Gene Technology Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Gene Technology Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Bio-Gene Technology Ltd (BGT) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.63 Million ≈ $1.15 Million	AU$-2.54 Million ≈ $-1.80 Million	-1.563x	-58.38%
2024-06-30	AU$2.79 Million ≈ $1.97 Million	AU$-2.75 Million ≈ $-1.95 Million	-0.987x	+2.98%
2023-06-30	AU$3.22 Million ≈ $2.28 Million	AU$-3.28 Million ≈ $-2.32 Million	-1.017x	-14751.29%
2022-06-30	AU$6.27 Million ≈ $4.44 Million	AU$43.52K ≈ $30.79K	0.007x	+101.61%
2021-06-30	AU$4.25 Million ≈ $3.00 Million	AU$-1.83 Million ≈ $-1.29 Million	-0.430x	-56.90%
2020-06-30	AU$6.00 Million ≈ $4.25 Million	AU$-1.64 Million ≈ $-1.16 Million	-0.274x	+38.40%
2019-06-30	AU$4.95 Million ≈ $3.50 Million	AU$-2.20 Million ≈ $-1.56 Million	-0.445x	-29.44%
2018-06-30	AU$6.91 Million ≈ $4.89 Million	AU$-2.37 Million ≈ $-1.68 Million	-0.344x	-327.50%
2017-06-30	AU$9.07 Million ≈ $6.42 Million	AU$-729.15K ≈ $-515.92K	-0.080x	+90.93%
2016-06-30	AU$473.35K ≈ $334.92K	AU$-419.35K ≈ $-296.71K	-0.886x	-440.17%
2014-06-30	AU$290.03K ≈ $205.21K	AU$-47.57K ≈ $-33.66K	-0.164x	--

About Bio-Gene Technology Ltd

AU:BGT Australia Biotechnology

Market Cap

$4.32 Million

AU$6.10 Million AUD

Market Cap Rank

#28831 Global

#1590 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$0.34